Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel disease

作     者：Ya-Xiong Guo Xiong Yan Xu-Chang Liu Yu-Xiang Liu Chun Liu 

作者机构：Surgical Unit 1Shanxi Combined Traditional Chinese and Western Medicine HospitalTaiyuan 030072Shanxi ProvinceChina No.1 Clinical Medical SchoolShanxi Medical UniversityTaiyuan 030001Shanxi ProvinceChina Department of NephrologyShanxi Provincial People’s HospitalTaiyuan 030012Shanxi ProvinceChina 

出 版 物：《World Journal of Nephrology》 (世界肾病学杂志(英文))

年 卷 期：2025年第14卷第1期

页      面：6-12页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Inflammatory bowel disease Renal complications Artificial intelligence Long-term management Nephrotoxicity 

摘      要：In this editorial,we discuss the article by Singh et al published in World Journal of Nephrology,stating the need for timely adjustments in inflammatory bowel disease(IBD)patients long-term management *** is chronic and lifelong,with recurrence and remission cycles,including ulcerative colitis and Crohn s *** s exact etiology is unknown but likely *** to gut flora and immune *** intestinal symptoms,IBD can also affect various extrain-testinal manifestations such as those involving the skin,joints,eyes and urinary *** anatomical proximity of urinary system waste disposal to that of the alimentary canal makes early detection and the differentiation of such symptoms very *** studies show that IBD and it s first-line drugs have nephro-toxicity,impacting the patients life *** guidelines give very few references for kidney lesion *** et al s plan aims to improve treatment management for IBD patients with glomerular filtration rate decline,specifically those at *** of IBD patients are young and they need lifelong *** early therapy cessation,taking into account drug side effects,can be *** intelligence-driven diagnosis and treatment has a big potential for management improvements in IBD and other chronic diseases.